Referral bias in female functional hyperandrogenism and polycystic ovary syndrome

European Journal of Endocrinology

Volumn 173, Issue 5, 2015, Pages 603-610

  Luque Ramírez, Manuel ^a   Alpañés, Macarena ^a   Sanchón, Raul ^a,b   Fernández Durán, Elena ^a   Ortiz Flores, Andrés E ^a   Escobar Morreale, Héctor F ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

^b Refractive Surgeon at Clínica Baviera Madrid   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANTHROPOMETRY; ARTICLE; BLOOD DONOR; BODY MASS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; HIRSUTISM; HUMAN; HYPERANDROGENISM; MAJOR CLINICAL STUDY; OBESITY; OVARY POLYCYSTIC DISEASE; PATIENT REFERRAL; PREMENOPAUSE; PREVALENCE; PRIORITY JOURNAL; COMPLICATION; PHENOTYPE; POLYCYSTIC OVARY SYNDROME; SPAIN; STATISTICS AND NUMERICAL DATA;

ADULT; CROSS-SECTIONAL STUDIES; FEMALE; HIRSUTISM; HUMANS; HYPERANDROGENISM; OBESITY; PHENOTYPE; POLYCYSTIC OVARY SYNDROME; REFERRAL AND CONSULTATION; SPAIN;

EID: 84946070401     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-15-0646     Document Type: Article

References (29)

1. Lim SS, Norman RJ, Davies MJ & Moran LJ. The effect of obesity on polycystic ovary syndrome: a systematic review and meta-analysis. Obesity Reviews 2013 14 95-109. (doi:10.1111/j.1467-789X.2012.01053.x)
2. Luque-Ramirez M, Marti D, Fernandez-Duran E, Alpanes M, Alvarez-Blasco F & Escobar-Morreale HF. Office blood pressure, ambulatory blood pressure monitoring, and echocardiographic abnormalities in women with polycystic ovary syndrome: role of obesity and androgen excess. Hypertension 2014 63 624-629. (doi:10.1161/HYPERTENSIONAHA.113.02468)
3. Ezeh U, Yildiz BO & Azziz R. Referral bias in defining the phenotype and prevalence of obesity in polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 2013 98 E1088-E1096. (doi:10.1210/jc. 2013-1295)
4. Zhao Y & Qiao J. Ethnic differences in the phenotypic expression of polycystic ovary syndrome. Steroids 2013 78 755-760. (doi:10.1016/j.steroids.2013.04.006)
5. Sanchon R, Gambineri A, Alpanes M, Martinez-Garcia MA, Pasquali R & Escobar-Morreale HF. Prevalence of functional disorders of androgen excess in unselected premenopausal women: a study in blood donors. Human Reproduction 2012 27 1209-1216. (doi:10.1093/humrep/des028)
6. Ruiz Moreno E, del Pozo de la Calle S, Cuadrado Vives C, Valero Gaspar T, Avila Torres JM, Belmonte Cortés S & Varela Moreiras G. Encuesta de nutrición de la Comunidad de Madrid (ENUCAM). Madrid, Spain: Comunidad de Madrid, 2014. (available at: http://www.observatorio.naos.aesan.msssi.gob.es/docs/docs/documentos/ENUCAM-2014.pdf)
7. Escobar-Morreale HF, Sanchon R & San Millan JL. A prospective study of the prevalence of nonclassical congenital adrenal hyperplasia among women presenting with hyperandrogenic symptoms and signs. Journal of Clinical Endocrinology and Metabolism 2008 93 527-533. (doi:10.1210/jc.2007-2053)
8. Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, Janssen OE, Legro RS, Norman RJ, Taylor AE et al. The androgen excess and PCOS society criteria for the polycystic ovary syndrome: the complete task force report. Fertility and Sterility 2009 91 456-488. (doi:10.1016/j.fertnstert.2008.06.035)
9. National Institutes of Health. Evidence-based methodology workshop on polycystic ovary syndrome. Bethesda, MD, USA: NIH, 2012. (available at: https://prevention.nih.gov/docs/programs/pcos/FinalReport.pdf)
10. Escobar-Morreale HF, Carmina E, Dewailly D, Gambineri A, Kelestimur F, Moghetti P, Pugeat M, Qiao J, Wijeyaratne CN, Witchel SF et al. Epidemiology, diagnosis and management of hirsutism: a consensus statement by the androgen excess and polycystic ovary syndrome society. Human Reproduction Update 2012 18 146-170. (doi:10.1093/humupd/dmr042)
11. Hatch R, Rosenfield RL, Kim MH & Tredway D. Hirsutism: implications, etiology, and management. American Journal of Obstetrics and Gynecology 1981 140 815-830.
12. Vermeulen A, Verdonck L & Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. Journal of Clinical Endocrinology and Metabolism 1999 84 3666-3672. (doi:10.1210/jcem.84.10.6079)
13. Alpanes M, Luque-Ramirez M, Martinez-Garcia MA, Fernandez-Duran E, Alvarez-Blasco F & Escobar-Morreale HF. Influence of adrenal hyperandrogenism on the clinical and metabolic phenotype of women with polycystic ovary syndrome. Fertility and Sterility 2015 103 795-801 e792. (doi:10.1016/j.fertnstert.2014.12.105)
14. Newcombe RG. Two-sided CIs for the single proportion: comparison of seven methods. Statistics in Medicine 1998 17 857-872. (doi:10.1002/(SICI)1097-0258(19980430)17:8!857:AID-SIM777O3.0.CO;2-E)
15. Cinar N, Harmanci A, Demir B & Yildiz BO. Effect of an oral contraceptive on emotional distress, anxiety and depression of women with polycystic ovary syndrome: a prospective study. Human Reproduction 2012 27 1840-1845. (doi:10.1093/humrep/des113)
16. O'Reilly MW, Taylor AE, Crabtree NJ, Hughes BA, Capper F, Crowley RK, Stewart PM, Tomlinson JW & Arlt W. Hyperandrogenemia predicts metabolic phenotype in polycystic ovary syndrome: the utility of serum androstenedione. Journal of Clinical Endocrinology and Metabolism 2014 99 1027-1036. (doi:10.1210/jc.2013-3399)
17. Chen MJ, Yang WS, Yang JH, Chen CL, Ho HN & Yang YS. Relationship between androgen levels and blood pressure in young women with polycystic ovary syndrome. Hypertension 2007 49 1442-1447. (doi:10.1161/HYPERTENSIONAHA.106.083972)
18. Luque-Ramirez M, Mendieta-Azcona C, Alvarez-Blasco F & Escobar-Morreale HF. Androgen excess is associated with the increased carotid intima-media thickness observed in young women with polycystic ovary syndrome. Human Reproduction 2007 22 3197-3203. (doi:10.1093/humrep/dem324)
19. Moghetti P, Tosi F, Bonin C, Di Sarra D, Fiers T, Kaufman JM, Giagulli VA, Signori C, Zambotti F, Dall'Alda M et al. Divergences in insulin resistance between the different phenotypes of the polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 2013 98 E628-E637. (doi:10.1210/jc.2012-3908)
20. Calderon-Margalit R, Siscovick D, Merkin SS, Wang E, Daviglus ML, Schreiner PJ, Sternfeld B, Williams OD, Lewis CE, Azziz R et al. Prospective association of polycystic ovary syndrome with coronary artery calcification and carotid-intima-media thickness: the Coronary Artery Risk Development in Young Adults Women's study. Arteriosclerosis, Thrombosis, and Vascular Biology 2014 34 2688-2694. (doi:10.1161/ATVBAHA.114.304136)
21. Alvarez-Blasco F, Luque-Ramirez M & Escobar-Morreale HF. Obesity impairs general health-related quality of life (HR-QoL) in premeno-pausal women to a greater extent than polycystic ovary syndrome (PCOS). Clinical Endocrinology 2010 73 595-601. (doi:10.1111/j.1365-2265.2010.03842.x)
22. Liou TH, Yang JH, Hsieh CH, Lee CY, Hsu CS & Hsu MI. Clinical and biochemical presentations of polycystic ovary syndrome among obese and nonobese women. Fertility and Sterility 2009 92 1960-1965. (doi:10.1016/j.fertnstert.2008.09.003)
23. Escobar-Morreale HF & San Millan JL. Abdominal adiposity and the polycystic ovary syndrome. Trends in Endocrinology and Metabolism 2007 18 266-272. (doi:10.1016/j.tem.2007.07.003)
24. Randeva HS, Tan BK, Weickert MO, Lois K, Nestler JE, Sattar N & Lehnert H. Cardiometabolic aspects of the polycystic ovary syndrome. Endocrine Reviews 2012 33 812-841. (doi:10.1210/er.2012-1003)
25. Lim SS, Davies MJ, Norman RJ & Moran LJ. Overweight, obesity and central obesity in women with polycystic ovary syndrome: a systematic review and meta-analysis. Human Reproduction Update 2012 18 618-637. (doi:10.1093/humupd/dms030)
26. Alvarez-Blasco F, Botella-Carretero JI, San Millan JL & Escobar-Morreale HF. Prevalence and characteristics of the polycystic ovary syndrome in overweight and obese women. Archives of Internal Medicine 2006 166 2081-2086. (doi:10.1001/archinte.166.19.2081)
27. Taieb J, Mathian B, Millot F, Patricot MC, Mathieu E, Queyrel N, Lacroix I, Somma-Delpero C & Boudou P. Testosterone measured by 10 immunoassays and by isotope-dilution gas chromatography-mass spectrometry in sera from 116 men, women, and children. Clinical Chemistry 2003 49 1381-1395. (doi:10.1373/49.8.1381)
28. Andreani CL, Pierro E, Lanzone A, Lazzarin N, Capitanio G, Giannini P & Mancuso S. Effect of gonadotropins, insulin and IGF I on granulosa luteal cells from polycystic ovaries. Molecular and Cellular Endocrinology 1994 106 91-97. (doi:10.1016/0303-7207(94)90190-2)
29. Dewailly D, Lujan ME, Carmina E, Cedars MI, Laven J, Norman RJ & Escobar-Morreale HF. Definition and significance of polycystic ovarian morphology: a task force report from the Androgen Excess and Polycystic Ovary Syndrome Society. Human Reproduction Update 2014 20 334-352. (doi:10.1093/humupd/dmt061)